期刊文献+

左旋咪唑涂布剂对精神分裂症患者免疫指标与疗效的关系 被引量:1

A correlation study of immunological parameters and effect in schizophrenia treated with levamisole hydrochloride liniment
下载PDF
导出
摘要 目的 :探讨左旋咪唑涂布剂对精神分裂症患者免疫指标与疗效的关系。 方法 :将 10 1例患者随机分成两组 ,均以固定剂量氟哌啶醇治疗 ,研究组辅以左旋咪唑涂布剂治疗 ,对照组予蒸馏水涂抹。治疗前后分别查免疫球蛋白及补体成分 ,用简明精神病评定量表 (BPRS)、阳性症状量表 (SAPS)、阴性症状量表 (SANS)、临床疗效总评量表 (CGI)和副反应量表 (TESS)综合评定。 结果 :治疗后免疫球蛋白G(IgG)下降明显 ,且两组差异显著。各量表的减分率与治疗前IgG呈显著正相关。SANS减分率与治疗前后IgG差值呈显著正相关。 结论 :临床症状改善与IgG水平相关 ,且以阴性症状为主。 Objective:To evaluate the relationship between the immunological parameters and effect in schizophrenia treated with levamisole hydrochloride liniment. Method:101 inpatients were randomly allocated to two groups.Both were treated with haloperidol in fixed-dose of 0.25 mg/(kg.d) plus either levamisole hydrochloride liniment or distillation.Immunoproteins and complements were measured and the clinical effects were assessed with BPRS,SAPS,SANS and CGI at pre-and post-treatment.TESS was assessed at post-treatment. Results:The number of IgG decreased significantly after treatment.But the rates of reduced score of all rating scales were significantly correlated with the number of IgG at pre-treatment. The rates of reduced score of SANS was significantly correlated with the distance of IgG at pre-and post-treatment. Conclusion:The degree of clinical improvement,mainly in negative symptoms,is related to the level of IgG.
出处 《临床精神医学杂志》 2003年第6期346-347,共2页 Journal of Clinical Psychiatry
关键词 左旋咪唑 精神分裂症 免疫球蛋白 补体成分 Levamisole Schizophrenia Immunoproteins Complements
  • 相关文献

参考文献1

  • 1金卫东 姚升 于林宝 主编.精神医学新论[M].武汉:湖北科学技术出版社,1999.14-27.

同被引文献14

  • 1王惠玲,李秋英,王高华,舒畅,王晓萍,刘浩,段金莲,杨相升.精神分裂症首次发病患者弓形虫感染率及其对临床症状的影响[J].中华精神科杂志,2005,38(3):134-137. 被引量:12
  • 2王惠玲,王高华,李秋英,舒畅,王晓萍,吴建红.弓形虫隐性感染对精神分裂症患者临床表现的影响[J].中国心理卫生杂志,2006,20(1):40-42. 被引量:5
  • 3闫先侠,牛爱军.精神分裂症患者血清免疫球蛋白及补体含量分析[J].山东精神医学,2006,19(1):21-22. 被引量:13
  • 4Niebuhr DW,Millikan AM,Cowan DN,et al.Selected infectious Agents and Risk of Schizophrenia Among U.S.Millitary Personnel.Americam Journal of Psychiatry,2008,165:99-106.
  • 5Faith Dickerson,John Boromow,Cassie Stallings,et al.Toxoplasma gondii in Individuals with Schizophrernia:Association with clinical and Demographic Factors and with Mortality.Sch.izophrewia Bulletin,2007,33:737-740.
  • 6Zafer cetinkaya,suleyman Yazar,Omer Gecici,etal.Anti-Toxoplasma gondii Antibodes in Patients With Schizophrenia-Prelimnnary Findings in a Turkish Sample.Schizophrenia Balletin,2007,33(3):789-791.
  • 7Alan S,Brown.Prenatal Infection as a Risk Factor for Schizophrenia.Schizophrenia Bulletin,2006,32(2):200-202.
  • 8Mortensen PB,Norgaard-Pedersen B,Waltoft BL,et al.Early Infections of Toxoplasma gondii and the Later Development of Schizophrenia.Schizophrenia Bulletin,2007,33(3):741.744.
  • 9Schwarcz R,Hunter CA.Toxoplasma gondii and Schizophrenia:Linkage Through Astrotyte-Derived Kynurenic Acid? Schizophrenia Bulletin,2007,33(3):652-653.
  • 10Dunja Hinze-Selch,Walter Danbener,Lena Eggert,et al.A Controlled Prospectine Study of Toxoplasma gondii Infection in lndividuals With Schizophrenia:Beyond Seroprevalenlce.Schizophrenia Bnlletin,2007,33(3):782-788.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部